News Daily News Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology Yael L. Maxwell June 24, 2016
News Industry News New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events September 08, 2015
News Daily News Outlook for Avoiding or Surviving Acute CVD, Stroke Much Improved Over Past Decade September 02, 2014
Presentation Trends in Hospitalization and Outcomes for Acute CVD and Stroke, 1999-2011 Presenter: Harlan M. Krumholz August 29, 2014